Divalproex Sodium
These highlights do not include all the information needed to use DIVALPROEX SODIUM DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DIVALPROEX SODIUM DELAYED-RELEASE TABLETS. DIVALPROEX SODIUM delayed-release tablets, for oral use Initial U.S. Approval: 1983
b95494e2-ee7a-7415-e053-2995a90ae852
HUMAN PRESCRIPTION DRUG LABEL
Sep 30, 2023
BluePoint Laboratories
DUNS: 985523874
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Divalproex Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (25)
Divalproex Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (24)
Divalproex Sodium
Product Details
FDA regulatory identification and product classification information